Omega-3 Fatty Acid Supplementation in Older Adults

University of Memphis

Status: Withdrawn

Conditions: Inflammation

Treatments: Dietary Supplement: Placebo; Dietary Supplement: Omega-3 fatty acid

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01666392

#2232 (Other Identifier)

Details and patient eligibility

About

The purpose of this study to determine whether Fish oil (Omega-3 Fatty Acid) supplementation has an impact on inflammation and lean body mass in older adults. The investigators expect that Fish oil supplementation will reduce inflammation and prevent the loss of lean mass compared to placebo.

Sex: All

Ages: 60+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 60 years of age or over

Exclusion criteria

• Fish, seafood allergies, nut allergies, soy allergies
• Habitual (>1/week) fish or seafood consumption
• Current Omega-3 supplement use
• Gastrointestinal problems
• Current anti-inflammatory medication use
• Current anticoagulant medication use

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

0 participants in 2 patient groups, including a placebo group

Fish oil (Omega-3 fatty acid)

Experimental group

Description:

2 capsules/day of ProOmega providing 650mg EPA and 450mg DHA

Treatment:

Dietary Supplement: Omega-3 fatty acid

Soybean oil

Placebo Comparator group

Description:

2 capsules/day

Treatment:

Dietary Supplement: Placebo